Imiquimod increases tumor cell apoptosis by shifting the pro- and anti-apoptotic Bcl factors toward the pro-apoptotic Bax protein and by stimulating the release of mitochondrial cytochrome c into the cytosol, activating caspase-9 and caspase-3 (9, 10). Here, CASP3 is linked to neoplasm.